Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Zoumpoulidou G, Alvarez-Mendoza C, Mancusi C, Ahmed RM, Denman M, Steele CD, Tarabichi M, Roy E, Davies LR, Manji J, Cristalli C, Scotlandi K, Pillay N, Strauss SJ, Mittnacht S.
Zoumpoulidou G, et al. Among authors: mittnacht s.
Nat Commun. 2021 Dec 3;12(1):7064. doi: 10.1038/s41467-021-27291-8.
Nat Commun. 2021.
PMID: 34862364
Free PMC article.